LCM
TTPH

Landscape Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Landscape Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,189
Closed -$640K – 926
2015
Q4 		$640K Buy
+3,189
New +$636K 0.08% 343

Other funds holding TTPH

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Landscape Capital Management's TTPH Position: Q1 2016 in Review

Landscape Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2016, closing a stake of 3,189 shares — an estimated $640K sold.

Landscape Capital Management first reported a position in TTPH in Q4 2015 and held it in 1 quarter. The position peaked at $640K in Q4 2015. 101 funds tracked by Wall St. Rank hold TTPH as of Q1 2016.

  • Landscape Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Landscape Capital Management sold 3,189 Tetraphase Pharmaceuticals, Inc. shares in Q1 2016, an estimated $640K.
  • Landscape Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2015 and held it in 1 quarter.
  • Landscape Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $640K in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2016.

Based on Landscape Capital Management's 13F filing for Q1 2016, filed 11 May 2016.